systfsb/data/attachment/portal/202108/11 |
您所在的位置:网站首页 › systfsb/data/attachment/portal/202108/11 |
data-id="" >http://paper.zjjnews.cn:8081张家界日报 - zjjnews.cn网页3 天之前 · 国内统一刊号:CN43-0020 张家界日报社出版 新闻热线:0744-8380702 广告热线:0744-8380701
发布时间:2024-05-12data-id="" >europa.euhttps://www.ema.europa.eu/en/documents/procedural...[PDF]Tysabri - European Medicines Agency网页2024年3月25日 · IB/0134 C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation 05/09/2022 n/a PSUSA/2127/ 202108 Periodic Safety Update EU Single assessment - natalizumab 24/03/2022 30/05/2022 SmPC Refer to Scientific conclusions and grounds recommending
发布时间:2024-05-12CopyRight 2018-2019 实验室设备网 版权所有 |